Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-19

Clinical Trial Update: Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tolerability and efficacy of Sodium Picosulfate/Magnesium Citrate versus PEG/Ascorbic Acid in patients with Ulcerative Colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PEG/Ascorbic Acid
  • Sodium picosulfate/magnesium citrate (sodium picosulfate; magnesium citrate)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Ulcerative Colitis | Phase 4 | Status: UNKNOWN